← Back to all trials
Not Yet Recruiting
NCT07677254
A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms, Castration-Resistant
Sex: Male
Ages: 18 Years – 115 Years
Healthy volunteers: No
Enrollment: 17111
Sponsor: Novartis Pharmaceuticals
Summary
The aim of this study is to assess treatment patterns, clinical outcomes, and patient characteristics among adults with metastatic castration-resistant prostate cancer (mCRPC) in the United States (US) real-world clinical practice. This study will be conducted using data extracted from the PRECISION (PRostatE Cancer dISease observatION) data platform.
Eligibility Criteria
Inclusion criteria:
* Diagnosis of mCRPC between 01 January 2021 and 31 December 2025.
* Male sex at index, where index is the date of initial mCRPC diagnosis.
* Age 18 years at index.
Exclusion criteria:
• None
Source: ClinicalTrials.gov (NCT07677254). StuddyBuddy aggregates publicly available trial information.
